Laboratory Products
New Monoclonal Antibodies to Clostridia GDH
Aug 21 2020
Clostridium difficile associated diarrhoea (CDAD) is the leading cause of nosocomial diarrhoea. The spread of this bacterium is difficult to control due to its resistant spores that survive on many surfaces. Thus rapid detection is crucial to its control. Most rapid tests target the toxins (A & B) produced during the infection.
Another diagnostic target is glutamate dehydrogenase (GDH), an enzyme produced and released during bacterial growth. Studies have shown that adding GDH detection together with toxin detection by EIA or PCR significantly improves assay specificity.
ViroStat announces the release of new monoclonal antibody pairs to Clostridia GDH validated by ELISA. These antibodies represent a new set of tools for rapid detection development.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark
Aug 28 2024 Phnom Penh, Cambodia
Sep 04 2024 Chiba, Tokyo, Japan
Sep 04 2024 University of Warwick, Coventry, UK